DUSSELDORF, Germany, July 1 /CNW/ - Gerresheimer AG, a leading
manufacturer of glass and plastic products for the pharma & life science
industry, has sold its Technical Plastics operations, which are not part of
the MDAX company's core business, to the FBH Group, Bad Soden, Germany.
"Through the sale of the Technical Plastics segment Gerresheimer has - as
formerly announced - taken a further step in its focus on the core business of
pharma & life science," says Dr. Axel Herberg, CEO of Gerresheimer AG.
The Technical Plastics business has so far been part of Gerresheimer
Wilden GmbH. Complex injection-molded plastic components for the automobile
industry are manufactured by around 430 employees at plants in Germany, the
Czech Republic and Mexico. Sales by this business, including the tool business
which is also being sold, totaled EUR74m in the financial year 2008.
The purchaser is a company in the FBH Group, Bad Soden, to which
Thermoplast Technik Beteiligungs-AG, a medium-sized manufacturer of
injection-molded parts, belongs. Components for the automobile industry are
manufactured in five production plants. Through the sale, FBH will expand its
plant network and existing product range.
The purchase price including the debts taken over amounts to EUR12m. The
transfer takes place with effect from July 1, 2009.
Gerresheimer employs around 10,000 people in 40 locations in Europe,
America and Asia. In the financial year 2008, worldwide sales totaled
EUR1.06bn. The product portfolio ranges from pharmaceutical vials made of
glass and plastic through to complex drug-delivery systems for the pharma &
life science industry. These include sterile syringes, inhalers and other
system-based approaches for safe dosage and application of medications. The
Group enjoys a leading position in markets which are characterized by high
technical and regulatory barriers.
For further information:
For further information: Contact Press, Burkhard Lingenberg, Director
Corporate Communication & Marketing, Phone +49-211-6181-250, Fax
+49-211-6181-241, e-mail email@example.com; Contact Investor
Relations, Anke Linnartz, Director Corporate Investor Relations, Phone
+49-211-6181-314, Fax +49-211-6181-121, e-mail firstname.lastname@example.org